Br. Slaap et al., MHPG AND HEART-RATE AS CORRELATES OF NONRESPONSE TO DRUG-THERAPY IN PANIC DISORDER PATIENTS - A PRELIMINARY-REPORT, Psychopharmacology, 127(4), 1996, pp. 353-358
Little is known about biological predictors of treatment response in p
anic disorder (PD). In the present study heart rate, blood pressure, p
lasma cortisol and plasma MHPG were investigated at baseline in a samp
le of 44 PD patients as possible predictors for nonresponse to treatme
nt. We used a strict definition of nonresponse to find patients who di
d not respond at all after 12 weeks of treatment with brofaromine or f
luvoxamine. Patients were considered nonresponders when they fulfilled
two criteria: they did not show a 50% reduction of agoraphobic avoida
nce and they still experienced panic attacks at endpoint. The variable
s that differed significantly between the groups were used to predict
nonresponse to drug therapy. Using this strict definition of nonrespon
se, 15 patients (32.6%) were considered nonresponders. These patients
were characterised by a higher plasma MHPG concentration and a higher
heart rate at baseline. These variables were subsequently used to pred
ict nonresponse.